Home | CE Accreditation | Faculty | Scientific Agenda | Case Vignettes | General Info/Accommodations | Register | Contact

New International Lung Adenocarcinoma Classification
William D. Travis, MD

Emerging Lung Cancer Sub-Types: EML4-ALK Mutant;
KRAS Mutant in Non-Smokers
Alice T. Shaw, MD, PhD

Revision of Lung Cancer TNM Classification
Harvey I. Pass, MD

Beyond First-Line Therapy in NSCLC: Timing and Choices
Edward S. Kim, MD

Multidisciplinary Management of Early Stage NSCLC
Moderator: Robert J. Cerfolio, MD, FACS, FCCP

Peri-Operative Therapy for Early NSCLC:
Different Approaches for Smokers and Non-Smokers?
Mark G. Kris, MD

Role of Surgery in Stage III NSCLC
Robert J. Cerfolio, MD, FACS, FCCP

Genomics and Early Stage NSCLC
Robert J. Cerfolio, MD, FACS, FCCP

Lunch and Learn
Chair: Fadlo R. Khuri, MD

Smoking Cessation and the Lung Cancer Epidemic in the 20th Century: Interim Report Card
Michael J. Thun, MD

Personalized Therapy in Advanced Lung Cancer
Moderator: Walter J. Curran Jr, MD

Markers to Predict Response to Chemotherapy in Advanced NSCLC
Rodolfo E. Bordoni, MD

Integrating Molecular Markers and Targeted Therapies
in Advanced NSCLC
Suresh S. Ramalingam, MD

Novel Agents in Development for Lung Cancer
Fadlo R. Khuri, MD

Special Topics in Lung Cancer Management
Moderator: Chandra P. Belani, MD

Combined Modality in the Management of Locally Advanced NSCLC: Blending Chemotherapy, Radiation, and Targeted Therapy
Walter J. Curran Jr, MD

Maintenance Therapy in the Advanced NSCLC: Definitions and Indications
Chandra P. Belani, MD